Tenax Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Tenax Therapeutics has a total shareholder equity of $8.1M and total debt of $500.9K, which brings its debt-to-equity ratio to 6.2%. Its total assets and total liabilities are $11.7M and $3.6M respectively.
Key information
6.2%
Debt to equity ratio
US$500.90k
Debt
Interest coverage ratio | n/a |
Cash | US$9.79m |
Equity | US$8.10m |
Total liabilities | US$3.59m |
Total assets | US$11.68m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: TENX's short term assets ($11.7M) exceed its short term liabilities ($3.6M).
Long Term Liabilities: TENX has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: TENX has more cash than its total debt.
Reducing Debt: TENX's debt to equity ratio has increased from 0% to 6.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TENX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: TENX has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 4.8% each year.